Explore
Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth
ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth
Read More
Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase
Read More
Trendline
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Read More
Trendline
Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development
Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development
Read More
Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
Read More
Trendline
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Read More
Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO to Strengthen Leadership Amid Growth
TRIANA Biomedicines Appoints Mohan Bala as COO to Strengthen Leadership Amid Growth
Read More
Trendline
Andelyn Biosciences Launches New Platform for Lentiviral Vector Manufacturing
Andelyn Biosciences Launches New Platform for Lentiviral Vector Manufacturing
Read More
Trendline
Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth
Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth
Read More
Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Read More
Trendline
Harbour BioMed Advances AI-Enabled Drug Candidate LET003 for Obesity Treatment
Harbour BioMed Advances AI-Enabled Drug Candidate LET003 for Obesity Treatment
Read More
Trendline
Secretome Therapeutics to Participate in Summer 2026 Investor Conferences
Secretome Therapeutics to Participate in Summer 2026 Investor Conferences
Read More
